Success Stories

While there have been countless success stories from Case Western Reserve University startups, a handful of our companies have enjoyed particularly notable exits.

Lucid Diagnostics

Lucid Diagnostics completed a $70 million initial public offering in 2021. The company’s  esophageal cancer prevention tests were developed jointly by medical school faculty at CWRU and University Hospitals. Learn more about Lucid Diagnostics.

Rodeo Therapeutics

Publicly traded biopharmaceutical company Amgen acquired Rodeo Therapeutics Corp. for $55 million in 2020, with the potential for up to $666 million if developmental milestones are reached. Learn more about Rodeo Therapeutics.


In 2020, Peak Nanosystems acquired PolymerPlus, a Cleveland-based polymeric development company founded at CWRU, for $25 million.

NervGen Pharma 

Vancouver-based NervGen Pharma Corp., a company founded to develop regenerative-medicine technology licensed from CWRU, raised about $7.5 million from an initial public offering in 2019. Learn more about NervGen Pharma.

View More of Our Startup Portfolio 

By the Numbers 

$50 million+ 

Amount of follow-on investment CWRU startups have attracted


Startup companies from CWRU since 2001

$600 million+

Amount raised by CWRU’s portfolio of spinoffs since 2017

Get in Touch

Looking to launch your own startup at Case Western Reserve University? We’re here to help.